← FDA Drug Approvals (Drugs@FDA)

DALFAMPRIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2017-01-23

Drug application

FDA Application #

ANDA206836

Application type

Abbreviated New Drug Application (Generic)

Brand name

DALFAMPRIDINE

Generic name

DALFAMPRIDINE

Active ingredients

DALFAMPRIDINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS LABS FL INC

Manufacturer

Actavis Pharma, Inc.

First approval

2017-01-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown